Breaking News Instant updates and real-time market news.

HRS

Harris

$162.73

-2.15 (-1.30%)

18:59
08/15/18
08/15
18:59
08/15/18
18:59

Harris initiated with a Neutral at UBS

UBS analyst Myles Walton initiated coverage of the Aerospace & Defense sector, starting Harris with a Neutral rating and $175 price target.

HRS Harris
$162.73

-2.15 (-1.30%)

05/08/18
05/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Advance Auto Parts (AAP) upgraded to Overweight from Neutral at Atlantic Equities with analyst Sam Hudson saying he expects an inflection in comps and margins when the company reports towards the end of May. 2. Northrop Grumman (NOC) and Harris (HRS) were upgraded to Conviction Buy from Buy at Goldman Sachs. 3. Louisiana-Pacific (LPX) upgraded to Buy from Neutral at DA Davidson with analyst Steven Chercover saying while the oriented strand board prices are near or at their peak, the company's blend of earnings power, balance sheet liquidity, and sales mix offer a "compelling value" at the stock's current price level. 4. Columbia Property (CXP) upgraded to Buy from Neutral at Goldman Sachs with analyst Andrew Rosivach saying he sees an attractive entry point at current share levels. 5. Loma Negra (LOMA) upgraded to Buy from Hold at HSBC and to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/22/18
FBCO
05/22/18
NO CHANGE
Target $175
FBCO
Outperform
Harris price target lowered to $175 from $189 at Credit Suisse
Credit Suisse analyst Robert Spingarn lowered his price target for Harris to $175 from $189 as he downgrades his outlook for Defense hardware stocks to neutral from bullish. The analyst reiterates an Outperform rating on the shares.
07/05/18
ARGS
07/05/18
NO CHANGE
Target $170
ARGS
Buy
Harris price target lowered to $170 from $196 at Argus
Argus analyst John Eade lowered his price target on Harris to $170 from $196 after a 8.4% decline in its stock price over the past quarter as a result of the "ongoing trade and tariff concerns" stemming from "presidential tweets". Eade keeps his Buy rating however and believes that the pullback offers a buying opportunity, saying the company stands to benefit from a "substantial increase in military spending following the March 2018 federal budget agreement" with solid earnings growth expected in 2018 and beyond. The analyst also notes that the slight valuation premium for Harris on price to sales multiple is deserved given his forecast for the company's earnings growth.
08/01/18
FBCO
08/01/18
NO CHANGE
Target $190
FBCO
Outperform
Harris price target raised to $190 from $175 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Harris to $190 from $175 after the company reported a largely in-line quarter and FY19 guide, while raising its medium-term guidance, calling for high-single digit growth across its Communication Systems and Electronic Systems segments, and indicating further potential upside to margins of 30.0% and 18.6%, respectively. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,920.36

2.61 (0.14%)

, SIG

Signet Jewelers

$64.47

-2.16 (-3.24%)

11:55
09/24/18
09/24
11:55
09/24/18
11:55
Periodicals
Amazon applies for patent for 'online retail sales of jewelry,' BI reports »

Amazon (AMZN) has applied…

AMZN

Amazon.com

$1,920.36

2.61 (0.14%)

SIG

Signet Jewelers

$64.47

-2.16 (-3.24%)

TIF

Tiffany

$125.58

-1.05 (-0.83%)

DGSE

DGSE Companies

$0.57

(0.00%)

BGI

Birks Group

$1.30

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

BTHE

Boston Therapeutics

$0.00

(0.00%)

11:55
09/24/18
09/24
11:55
09/24/18
11:55
Hot Stocks
Boston Therapeutics starts study of BTI320 on type 2 diabetics on metformin »

Boston Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$150.80

-2.02 (-1.32%)

11:55
09/24/18
09/24
11:55
09/24/18
11:55
Options
Deere put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
09/24/18
09/24
11:55
09/24/18
11:55
Conference/Events
RBC Capital multi-industry analyst to hold group luncheon »

Multi-Industry Analyst…

BSX

Boston Scientific

$38.14

0.38 (1.01%)

11:55
09/24/18
09/24
11:55
09/24/18
11:55
Conference/Events
Boston Scientific to hold an investor event »

In conjunction with the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 09

    Oct

11:45
09/24/18
09/24
11:45
09/24/18
11:45
General news
Treasury's $90 B 3- and 6-month bill sale was well received »

Treasury's $90 B 3-…

SPPI

Spectrum

$21.04

-0.33 (-1.54%)

11:44
09/24/18
09/24
11:44
09/24/18
11:44
Hot Stocks
Spectrum announces preliminary poziotinib data from Phase 2 study »

Spectrum Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

SNE

Sony

$57.01

-0.025 (-0.04%)

, NTDOY

Nintendo

$0.00

(0.00%)

11:43
09/24/18
09/24
11:43
09/24/18
11:43
Periodicals
Sony to cease manufacturing PlayStation Vita in 2019, BI reports »

According to a recent…

SNE

Sony

$57.01

-0.025 (-0.04%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$9.95

6.95 (231.67%)

11:43
09/24/18
09/24
11:43
09/24/18
11:43
Recommendations
Amarin analyst commentary  »

Citi sees about five…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

RAD

Rite Aid

$1.24

-0.025 (-1.98%)

11:40
09/24/18
09/24
11:40
09/24/18
11:40
Options
10K Rite Aid Jan 1 puts trade for 9c on ISE »

10K Rite Aid Jan 1 puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

JPM

JPMorgan

$117.18

-0.66 (-0.56%)

11:38
09/24/18
09/24
11:38
09/24/18
11:38
Hot Stocks
JPMorgan's Dimon says hasn't spoken to president since election comments »

JPMorgan CEO Jamie Dimon,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 28

    Sep

  • 12

    Oct

  • 21

    Oct

  • 26

    Feb

MDT

Medtronic

$98.36

0.51 (0.52%)

11:36
09/24/18
09/24
11:36
09/24/18
11:36
Hot Stocks
Medtronic announces five-year data with CoreValve TAVR system »

Medtronic announced new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 26

    Sep

  • 09

    Oct

11:35
09/24/18
09/24
11:35
09/24/18
11:35
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

11:34
09/24/18
09/24
11:34
09/24/18
11:34
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

11:34
09/24/18
09/24
11:34
09/24/18
11:34
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

ERIC

Ericsson

$8.91

0.12 (1.37%)

11:32
09/24/18
09/24
11:32
09/24/18
11:32
Hot Stocks
Ericsson secures CBRS certification from FCC »

Ericsson announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$37.76

0.075 (0.20%)

11:30
09/24/18
09/24
11:30
09/24/18
11:30
Hot Stocks
AstraZeneca says European Commission grants marketing authorization for Imfinzi »

AstraZeneca and MedImmune…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$11.67

-0.505 (-4.15%)

11:30
09/24/18
09/24
11:30
09/24/18
11:30
Options
Flurry of activity in GE calls as shares fall to multi-year lows »

Flurry of activity in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

11:30
09/24/18
09/24
11:30
09/24/18
11:30
General news
Treasury 2-year auction outlook »

Treasury 2-year auction…

NWL

Newell Brands

$20.22

-1.61 (-7.38%)

, SHLD

Sears

$1.17

-0.115 (-8.95%)

11:25
09/24/18
09/24
11:25
09/24/18
11:25
Recommendations
Newell Brands, Sears analyst commentary  »

Newell weakness on…

NWL

Newell Brands

$20.22

-1.61 (-7.38%)

SHLD

Sears

$1.17

-0.115 (-8.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$5.68

-0.265 (-4.46%)

11:25
09/24/18
09/24
11:25
09/24/18
11:25
Options
Fitbit call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:25
09/24/18
09/24
11:25
09/24/18
11:25
General news
Treasury announced a $40 B 4-week bill sale for Tuesday »

Treasury announced a $40…

11:25
09/24/18
09/24
11:25
09/24/18
11:25
Conference/Events
RBC Capital multi-industry analyst to hold group luncheon »

Multi-Industry Analyst…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
09/24/18
09/24
11:17
09/24/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$218.75

1.1 (0.51%)

11:16
09/24/18
09/24
11:16
09/24/18
11:16
Hot Stocks
Apple completes acquisition of Shazam »

Apple announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.